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were reviewed through an environmental scan of the scientific literature. Additionally, international regulatory
bodies were asked whether the terms "nutrient" and/or "essential nutrient" are regulated in their respective
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currently possess regulated definitions for the term "essential nutrient". Case studies examining fibre, plant
sterols and polyphenols served as a means of presenting evidence for expanding the list of functional food
constituents regarded as meeting criteria for essentiality. For each example, certain instances applied where
these case study bioactives met criteria of essentiality. Thus, in order to reflect advances in current science, a
series of non-classical compounds known to have bioactivity should be considered for their potential
essentiality under certain situations.
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Abstract 
With increased understanding of the complex roles nutrients play within metabolic pathways, the 
purpose of this contribution is to explore the rationale for expanding the definitions and criteria 
for nutrient essentiality. A further objective was to develop three case study scenarios to probe 
issues surrounding the definition of essentiality using dietary fibre, plant sterols and polyphenols.  
Current definitions and criteria for “essentiality” were reviewed through an environmental scan 
of the scientific literature. Additionally, international regulatory bodies were asked whether the 
terms “nutrient” and/or “essential nutrient” are regulated in their respective jurisdictions. 
Regulatory bodies including EFSA, FSANZ, HC and the US FDA were found not to currently 
possess regulated definitions for the term “essential nutrient”. Case studies examining fibre, plant 
sterols and polyphenols served as a means of presenting evidence for expanding the list of 
functional food constituents regarded as meeting criteria for essentiality. For each example, 
certain instances applied where these case study bioactives met criteria of essentiality.  Thus, in 
order to reflect advances in current science, a series of non-classical compounds known to have 
bioactivity, should be considered for their potential essentiality under certain situations. 
Key words: nutrient, essentiality, fibre, plant sterols, polyphenols 
 
 4
1. Introduction 
From a clinical perspective, evidence for nutrient essentiality dates as far back as the 
1670s when a British physician, Sydenham, reported observations that a tonic of iron filings 
produced improved clinical responses in anemic patients (Harper, 1993).  However, it was not 
until 1906 that essentiality for life, and of a specific organic molecule, was established when 
Willcock and Hopkins showed that a supplement of the amino acid tryptophan prolonged 
survival in mice given a tryptophan-deficient diet (Harper, 1993). By 1950, some 35 nutrients, 
including various essential fatty acids, amino acids, vitamins and minerals, had been identified as 
essential (Harper, 1999). For the most part, single nutrients were chemical compounds with a 
definable chemical structure, which may occur in clusters.  In general terms, a nutrient was 
deemed essential when its removal caused a state of metabolic and/or clinical hypofunction, 
which could be normalized when that nutrient was added back in the diet. More recently, it could 
be argued that the notion of essentiality has been broadened. A new definition is one which goes 
beyond the level needed for minimal support for normal growth, development and maintenance 
of health to affording a level of protection against chronic degenerative diseases, if consumed 
beyond this minimal requirement. Therefore, the objective of this paper is to review current 
definitions and criteria for nutrient essentiality, and to present three case studies with a 
supportive rationale for why some food constituents should be re-evaluated in terms of their 
essentiality for specific populations and/or physiological conditions.  
 
2. Methods 
An environmental scan of the literature was conducted January, 2013 using combinations 
of the terms “criteria”, “definition”; and “essential nutrient”, “nutrient essentiality”, 
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“conditionally essential nutrient” within the search engines PubMed and Google Scholar. No 
limits on the year of publication or language were used. Three contemporary nutrition textbooks 
were also consulted (Shils et al., 1999; Erdman et al., 2012; Whitney & Rolfes, 2002). Hand 
searching within the reference lists of textbooks and articles identified from the environmental 
scan was also conducted to locate further definitions and identify criteria for the aforementioned 
terms. 
Additionally, inquiries were forwarded to international regulatory bodies including 
Health Canada (HC), the U.S. Food and Drug Administration (US FDA), the European Food 
Safety Authority (EFSA) and Food Standards Australia New Zealand (FSANZ), as well as 
international organizations including the Institute of Medicine (IOM) and the Australian 
Government’s National Health and Medical Research Council (NHMRC), asking whether the 
terms “nutrient” and/or “essential nutrient” are regulated in their respective jurisdictions.  
Three case studies were also developed for the food constituents fibre, plant sterols, and 
polyphenols, components not currently considered as essential nutrients but possessing desirable 
health effects. A draft report was then reviewed and discussed by a group of international 
nutritional science experts. 
 
3. Results 
Based on current definitions, a “nutrient” is first and foremost considered a component of 
food useful to an organism for its growth, or functioning. More pragmatically, a nutrient is one 
for which a ‘Nutrient Reference Value’ (NRV) exists, the NRV provides a level to meet 
requirements for health (Codex Alimentarius Commission, 1985). Nutrients tend to belong to 
one of six broad categories: minerals, water, carbohydrates, lipids, proteins and vitamins; and 
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they provide energy or structural materials and regulating agents to support growth, maintenance 
and repair of the body’s tissues as well as being needed for growth, development, and 
maintenance of a healthy life. A deficit of a nutrient will cause characteristic biochemical or 
physiological changes to occur. The intake of certain nutrients at a particular level may reduce 
the risk of some diseases (Codex Alimentarius Commission, 1991; European Commission, 2006; 
2002).  
“Non-nutrients” tend to be defined as food constituents which do not fit in the six 
aforementioned categories, but contribute in a general manner to body functioning. This category 
can include phytochemicals, pigments and additives (Whitney & Rolfes, 2002) and generally 
speaking do not possess defined NRVs. The European Commission (EC) Regulation (No. 
1924/2006) defines “other substance”, in the context of health claims, as any substance other 
than a nutrient which has a nutritional or physiological effect (European Commission, 2006).  
Regulatory bodies including EFSA, FSANZ, HC and the US FDA do not currently report 
formal definitions for the term “essential nutrient” and generally referring to standard definitions 
found in appropriate textbooks. Definitions for the concept and categorization of “essential 
nutrient”, “non-essential nutrient”, and “conditionally essential nutrient” collated from various 
documents and textbook sources can be represented as a continuum (Figure 1) (Codex 
Alimentarius Commission, 1991; Harper, 1999; Whitney & Rolfes, 2002).   
Other terms have been proposed to describe food constituents which may not be 
considered “essential” in the traditional sense, yet provide additional health benefits. These terms 
include “lifespan essential” in reference to polyphenols (Williamson & Holst, 2008); 
“physiological modulators”, originally proposed for antioxidant vitamins, but also applicable to 
many other food constituents (Olson, 1996); and “desirable” (Steele, 1993). While the 
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description and concept for these food constituents differ across sources, they all refer to the 
potential of chronic degenerative disease risk reduction. The appearance of these proposed terms 
in the literature, suggests that there is an opportunity to review the working definitions of 
nutrients and of essentiality in light of advances in science. The following three case studies 
serve as a means of presenting a rationale for expanding the definitions and criteria for nutrient 
essentiality. 
 
4. Case studies 
4.1 Case study # 1: Fibre 
Dietary fibre has been defined by Codex  as: “…carbohydrate polymers with ten or more 
monomeric units, which are not hydrolysed by the endogenous enzymes in the small intestine of 
humans and belong to the following categories: Edible carbohydrate polymers naturally 
occurring in the food as consumed; carbohydrate polymers which have been obtained from food 
raw material by physical, enzymatic or chemical means and which have been shown to have a 
physiological effect of benefit to health as demonstrated by generally accepted scientific 
evidence to competent authorities; synthetic carbohydrates polymers which have been shown to 
have a physiological effect of benefit to health as demonstrated by generally accepted scientific 
evidence to competent authorities” (Codex Alimentarius Commission, 2008). 
While debate exists over whether fibre is indeed a nutrient (Marlett, 1993), the EC 
Regulation (No. 1924/2006) considers fibre to be a nutrient in relation to health claims 
(European Commission, 2006). Fibre is generally addressed in dietary guidelines and 
recommendations but it is not considered essential for growth, development or survival; 
however, we propose that certain fibres could be considered essential for specific populations or 
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uses, as fibre has been linked to a large number of health benefits. In fact health claims for 
various fibres, such as beta-glucans, arabinoxylan, wheat bran, psyllium and resistant starch, 
have been approved in relation to promotion of regularity/laxation, reduction of blood 
cholesterol, and reduction of post-prandial glycaemic responses in various jurisdictions including 
the European Union (EU), the United States, Canada and Australia/New Zealand (Table 1).  
Specific populations which could benefit from classifying certain fibres as essential include those 
with high blood cholesterol, or those who could benefit from reduction of post-prandial 
glycaemic responses. As such, the term essential deserves additional consideration in the context 
of varying physiological circumstances.  
From another perspective, the sub-group of fibres considered to be prebiotics could be 
considered essential as food for gastrointestinal microbiota, which are themselves a vital 
component of normal human physiology. Prebiotics have been defined as “a selectively 
fermented ingredient that results in specific changes, in the composition and/or activity of the 
gastrointestinal microbiota, thus conferring benefit(s) upon host health” (Gibson et al., 2011). 
The composition and activity of gastrointestinal microbiota are of interest since perturbed 
gastrointestinal microbiota balance has been increasingly associated with various disease states 
including, celiac disease, colon cancer, Type I and II diabetes, inflammatory bowel disease, 
irritable bowel syndrome, antibiotic-associated diarrhea, necrotising enterocolitis and obesity 
(Binns, 2013).  
In summary, fibre could be considered nominally essential in at least two different 
scenarios: 1) for specific sub-populations with certain conditions such as high cholesterol who 
could benefit from the cholesterol-lowering properties of specific fibres such as beta-glucans, 
and, 2) in the form of prebiotics as food for gastrointestinal microbiota. 
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4.2 Case study # 2: Plant sterols 
Plant sterols (PS) possess chemical structures and biological functions similar to 
cholesterol but are found in plants (Berger et al., 2004). Dietary sources of PS include vegetable 
oils, nuts, seeds, and grains (Berger et al., 2004). The cholesterol-lowering effect of plant sterols 
is well established and health claims for this food-health relationship have been approved in 
various jurisdictions around the world including the EU, Canada, the US, and Australia/New 
Zealand (Table 2). An intake of 1-2 g PS/day is required to produce an inhibitory action on 
cholesterol absorption and results in a decrease in circulating low-density lipoprotein cholesterol 
concentrations of 10-15%. However, current dietary intakes remain less than 300 mg/d (Jones & 
Varady, 2008). Based on this rationale, Jones and Varady previously suggested that PS be 
defined as essential under physiological situations where body cholesterol pools are high (Jones 
& Varady, 2008). In those situations, PS are required to prevent the over-absorption of biliary 
and dietary cholesterol, thus protecting against vascular disease and optimizing health through 
that action (Jones & Varady, 2008). As such, the absence of PS results in distorted cholesterol 
metabolism through hyper-absorption, meaning that these compounds can be deemed essential. 
It has been estimated that our ancestors in the Myocene era may have consumed 
approximately 1 g of PS daily (Jenkins et al., 2003), while as mentioned above current intakes of 
PS are less than 300 mg/day. At 1 g of PS per day, cholesterol absorption is suppressed at higher 
amounts; accordingly, dis-inhibition would result in hyper-absorption of cholesterol and thus 
increased risk of cardiovascular disease. In light of this information, it could be suggested that 
current North American diets are deficient in PS, thus providing further rationale for considering 
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PS an essential nutrient, particularly for those genetically predisposed to hyper-absorption of 
cholesterol. 
 
4.3 Case study # 3: Polyphenols 
Polyphenols are antioxidants which possess phenolic rings (Williamson & Holst, 2008) 
and are widely found in plant foods.  The potential human health benefits in relation to 
polyphenols have been of particular interest in the past 10-15 years and has covered research on 
cardiovascular disease, obesity, diabetes, gut microbiota (Tomás-Barberán & Andrés-Lacueva, 
2012). Evidence does exist for health benefits, thus a potential essential role based on in vitro 
studies, however, the purported health claims for the effect of polyphenols in vivo require further 
investigation. To date, the European Union has only approved one health claim related to 
polyphenols, specifically, olive oil polyphenols contributing to the protection of blood lipids 
from oxidative stress (European Commission, 2012). Health claims for polyphenols have not yet 
been approved in Canada, the United States or Australia/New Zealand. A consideration in 
evaluation of polyphenols in relation to human health is whether direct antioxidant effects exist 
in humans. For example, an ISLI Europe Functional Foods Expert Group investigated the 
antioxidant effect of polyphenols for cardiovascular health in humans (Hollman et al., 2011). 
This ILSI Expert Group found that retrospective studies showed differences in F2-isoprostanes, 
oxidized LDL, and measures of total antioxidant capacity (TAC) between cardiovascular disease 
patients and healthy controls; however, a casual relationship could not be found between these 
same biomarkers and cardiovascular health in prospective studies (Hollman et al., 2011). This 
group concluded that a direct antioxidant effect of polyphenols in vivo was unlikely since their 
levels in the systemic circulation and tissues are lower compared to those of other antioxidants, 
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and extensive metabolism after consumption results in a lowered antioxidant activity (Hollman et 
al., 2011). On these bases, it would appear further data are required before polyphenols could be 
deemed as essential.  
 
4.4 Case studies summary 
While fibre and PS may not be considered essential in the traditional sense, i.e., for 
growth, development or survival, the argument presented here suggests that these dietary 
constituents could be considered essential for specific populations and/or physiological 
conditions.  In the case of polyphenolic compounds, data are currently less compelling to suggest 
that under any circumstance can this category of compound be defined as essential.  Further 
research with specific individual phenolic constituents, together with reasonable physiological 
doses are required in order to ascertain whether any essentiality exists for molecules falling into 
this category.  These examples then broaden our lens through which the working definitions of 
essential nutrients might be placed in a wider perspective.  
A consideration in investigating the essentiality of a food constituent is what type of 
evidence is required to establish essentiality. Based on the above case studies, approved health 
claims could be a source for identifying food constituents with established health benefits; if this 
is the case, evidentiary requirements for food health claims could also be used to establish the 
need for those bioactives within our food systems.  Guidance for food health claim submissions 
from the United States (U.S. Food and Drug Administration, 2009), the European Union (EFSA 
Panel on Dietetic Products, Nutrition and Allergies, 2011), Canada (Health Canada, 2009), and 
Australia/New Zealand (Food Standards Australia New Zealand, 2013a) all emphasize the use of 
human studies, and while animal and/or in vitro studies can be submitted for a food health claim 
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dossier, these studies can generally only be considered as supportive evidence due to scientific 
uncertainties in the extrapolation of date from non-human data to humans.  In terms of the types 
of human evidence required in the evaluation of health claims, both observational and 
interventional studies can be useful in the context of the totality of evidence, however, it should 
be noted that only prospective studies should be included in food health claim submission, since 
retrospective studies cannot be used to establish a causal relationship. As a case in point, the 
polyphenol case study above showed that the ILSI Expert Group found changes in markers of 
lipid peroxidation in retrospective studies, while the same was not found for prospective studies 
(Hollman et al., 2011). 
 
5. Conclusion 
In nutritional science, the terms “nutrient” and “essential” possess specific meanings and 
applications, both involving the translation of scientific knowledge to policy and practice. While 
nutrients are food components, their pragmatic definition has been associated with a sense of 
essentiality. In the past, the recognition that a nutrient plays an essential role has been linked to 
its ability to prevent a specific deficiency disease or whether it can be synthesised by the human 
body. This review has argued that the definition of essential nutrients needs to be expanded to 
reflect advances in scientific knowledge. A broader appreciation of food components means that 
additional dietary constituents could be considered essential nutrients. The essentiality of a 
nutrient can thus be assessed with a wider view to why it is essential or what it is essential for.  
Case studies presented in this paper provide a rationale for expanding definitions and criteria for 
nutrient essentiality. Furthermore, the arguments presented in this paper for fibre, PS and 
polyphenolics to be considered as essential opens the door for further scientific investigation into 
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the potential essentiality of many additional food components, some of which have been referred 
to as “bioactives”- “essential and non-essential compounds such as vitamins or polyphenols that 
occur in nature, are part of the food chain, and can be shown to have an effect on human health” 
(Biesalski et al., 2009).  
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Table 1. Summary of approved fibre-related health claims in the European Union, the United 
States, Canada and Australia/New Zealand 
Food or food 
constituent 
Health relationship 
Alpha-cyclodextrin  Reduction of post-prandial glycaemic responses (European 
Commission, 2013) 
Arabinoxylan 
produced from wheat 
endosperm 
 Reduction of post-prandial glycaemic responses (European 
Commission, 2012) 
Barley and oat beta-
glucan 
 Reduction of blood cholesterol (European Commission, 2011a, 
2011b; Food Standards Australia New Zealand, 2013b; Health 
Canada, 2010a, 2012) 
 Reduction of dietary and biliary cholesterol absorption (Food 
Standards Australia New Zealand, 2013b) 
 Reduction of post-prandial glycaemic responses (European 
Commission, 2012) 
 Maintenance of normal blood cholesterol concentrations (European 
Commission, 2012) 
 Potential reduction in risk of coronary heart disease (Electronic Code 
of Federal Regulations, 2008) 
Barley grain fibre  Increase in faecal bulk (European Commission, 2012) 
Coarse wheat bran  Promotion of laxation/regularity (Canadian Food Inspection Agency, 
2011) 
Dietary fibre  Contribution to regular laxation (Food Standards Australia New 
Zealand, 2013b) 
Fiber-containing grain 
products, fruits, and 
vegetables 
 Potential reduction in risk of some cancers (Electronic Code of 
Federal Regulations, 1993a) 
Fruits, vegetables, and 
grain products that 
contain fiber, 
particularly soluble 
fiber 
 Potential reduction in risk of coronary heart disease (Electronic Code 
of Federal Regulations, 1993b) 
Glucomannan (konjac 
mannan) 
 Reduction of body weight (European Commission, 2012) 
 Maintenance of normal blood cholesterol concentrations (European 
Commission, 2012) 
Guar gum  Maintenance of normal blood cholesterol concentrations (European 
Commission, 2012) 
Hydroxypropyl 
methylcellulose 
(HPMC) 
 
 Reduction of post-prandial glycaemic responses (European 
Commission, 2012) 
 Maintenance of normal blood cholesterol concentrations (European 
Commission, 2012) 
Lactulose  Acceleration of intestinal transit (European Commission, 2012) 
Oat grain fibre  Increase in faecal bulk (European Commission, 2012) 
Pectins  Reduction of post-prandial glycaemic responses (European 
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 Commission, 2012) 
 Maintenance of normal blood cholesterol concentrations (European 
Commission, 2012) 
Psyllium  Promotion of laxation/regularity (Canadian Food Inspection Agency, 
2011) 
 Reduction of blood cholesterol (Health Canada, 2011) 
 Potential reduction in risk of coronary heart disease (Electronic Code 
of Federal Regulations, 2008) 
Resistant starch  Reduction of post-prandial glycaemic responses (European 
Commission, 2012) 
Rye fibre  Changes in bowel function (European Commission, 2012) 
Wheat bran fibre  Reduction in intestinal transit time (European Commission, 2012) 
 Increase in faecal bulk (European Commission, 2012) 
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Table 2. Summary of approved health claims related to plant sterols and plant stanols in the 
European Union, the United States, Canada and Australia/New Zealand 
 
 
 Contribution to the maintenance of normal blood cholesterol levels. (European 
Commission, 2012)  
 
 Reduction of dietary and biliary cholesterol absorption. (Food Standards Australia 
New Zealand, 2013b ) 
 
 Reduction of blood cholesterol. (European Commission, 2009; European 
Commission, 2010a; European Commission, 2010b; Food Standards Australia 
New Zealand, 2013b; Health Canada, 2010b)  
 
 Potential reduction in risk of coronary heart disease (Electronic Code of Federal 
Regulations, 2005) 
 
 
 
 
 
 
 19
References 
 
Berger, A., Jones, P. J., & Abumweis, S. S. (2004). Plant sterols: factors affecting their efficacy 
and safety as functional food ingredients. Lipids in Health and Disease, 3, 5.  
Biesalski, H. K., Dragsted, L. O., Elmadfa, I., Grossklaus, R., Muller, M., Schrenk, D., . . . 
Weber, P. (2009). Bioactive compounds: definition and assessment of activity. Nutrition, 
25(11-12), 1202-1205.  
Binns, N. (2013). Probiotics, Prebiotics and the Gut Microbiotia. ILSI Europe Concise 
Monograph Series. 
Canadian Food Inspection Agency. (2011). 8.5.3 Summary Table of Acceptable Function Claims 
as Applied to Food or Food Constituents, Retrieved from 
http://inspection.gc.ca/english/fssa/labeti/guide/ch8e.shtml#a8_5_3 
Codex Alimentarius Commission. (1985). Guidelines on Nutrition Labelling.   
Codex Alimentarius Commission. (1991). General Principles for the Addition of Essential 
Nutrients to Foods CAC/GL 09-1987 (amended 1989, 1991). 
Codex Alimentarius Commission. (2008). ALINORM 09/32/26. Report of the 30th Session of 
the Codex Committee on Nutrition and Foods for Special Dietary Uses, Cape Town, 
South Africa, 3 - 7 November 2008. 
EFSA Panel on Dietetic Products, Nutrition and Allergies. (2011). Scientific and technical 
guidance for the preparation and presentation of an application for authorisation of a 
health claim (revision 1). EFSA Journal. 9(5), 2170. 
Electronic Code of Federal Regulations. (1993a). Health claims: fiber-containing grain products, 
fruits, and vegetables and cancer.  
 20
Electronic Code of Federal Regulations. (1993b). Health claims: fruits, vegetables, and grain 
products that contain fiber, particularly soluble fiber, and risk of coronary heart disease.  
Electronic Code of Federal Regulations. (2005). Health claims: plant sterol/stanol esters and risk 
of coronary heart disease (CHD).  
Electronic Code of Federal Regulations. (2008). Health claims: Soluble fiber from certain foods 
and risk of coronary heart disease (CHD).  
Erdman, J.W., Macdonald, I. A., & Zeisel, S.H. Present Knowledge in Nutrition. (2012).  (10th 
ed.): International Life Sciences Institute. 
European Commission. (2006). Regulation (EC) No 1924/2006 of the European Parliament and 
of the Council of 20 December 2006 on nutrition and health claims made on foods.   
European Commission. (2009).Commission Regulation (EC) No 983/2009 of 21 October 2009 
on the authorisation and refusal of authorisation of certain health claims made on food 
and referring to the reduction of disease risk and to children’s development and health 
(Text with EEA relevance).  
European Commission. (2010a). Commission Regulation (EU) No 376/2010 of 3 May 2010 
amending Regulation (EC) No 983/2009 on the authorisation and refusal of authorisation 
of certain health claims made on food and referring to the reduction of disease risk and to 
children’s development and health 2010. 
European Commission. (2010b). Commission Regulation (EU) No 384/2010 of 5 May 2010 on 
the authorisation and refusal of authorisation of certain health claims made on foods and 
referring to the reduction of disease risk and to children’s development and health. 
 21
European Commission. (2011a). Commission Regulation (EU) No 1048/2012 of 8 November 
2012 on the authorisation of a health claim made on foods and referring to the reduction 
of disease risk.  
European Commission. (2011b). Commission Regulation (EU) No 1160/2011 of 14 November 
2011 on the authorisation and refusal of authorisation of certain health claims made on 
foods and referring to the reduction of disease risk.  
European Commission. (2012). Commission Regulation (EU) No 432/2012 of 16 May 2012 
establishing a list of permitted health claims made on foods, other than those referring to 
the reduction of disease risk and to children’s development and health.  
European Commission. (2013). Commission Regulation (EU) No 536/2013 of 11 June 2013 
amending Regulation (EU) No 432/2012 establishing a list of permitted health claims 
made on foods other than those referring to the reduction of disease risk and to children’s 
development and health. 
Food Standards Australia New Zealand. (2013a). Guidance on establishing food-health 
relationships for general level health claims. 
Food Standards Australia New Zealand. (2013b). Standard 1.2.7 - Nutrition, Health and Related 
Claims.  
Gibson, G., Scott, K. P., Rastall, R. A., Tuohy, K. M., Hotchkiss, A., Dubert-Ferrandon, A., . . . 
Buddington, R. (2011). Dietary prebiotics: current status and new definition. Food 
Science and Technology Bulletin: Functional Foods 7(1), 1-19.  
Harper, A. E. (1993). Nutritional Essentiality: Historical Perspective. Paper presented at the 
Nutritional Essentiality: A Changing Paradigm, Report of the Twelfth Ross Conference 
on Medical Research. 
 22
Harper, A. E. (1999). Chapter 1. Defining the Essentiality of Nutrients. In M. E. Shils, J. A. 
Olson, M. Shike & A. C. Ross. (Eds.), Modern Nutrition in Health and Disease. 9th ed. 
(pp. p3-10.). Baltimore, Maryland: Lippincott Williams & Wilkins. 
Health Canada. (2009).Guidance document for preparing a submission for food health claims. 
Health Canada. (2010a). Summary of Assessment of a Health Claim about Oat Products and 
Blood Cholesterol Lowering.  
Health Canada. (2010b). Summary of Assessment of a Health Claim about Plant Sterols in Foods 
and Blood Cholesterol Lowering.  
Health Canada. (2011). Summary of Health Canada's Assessment of a Health Claim about Food 
Products Containing Psyllium and Blood Cholesterol Lowering.  
Health Canada. (2012). Summary of Health Canada's Assessment of a Health Claim about 
Barley Products and Blood Cholesterol Lowering.  
Hollman, P.C., Cassidy, A., Comte, B., Heinonen, M., Richelle, M., Richling, E., …Vidry S. 
(2011). The biological relevance of direct antioxidant effects of polyphenols for 
cardiovascular health in humans is not established. Journal of Nutrition, 141(5), 989S-
1009S. 
Jenkins, D. J., Kendall, C. W., Marchie, A., Jenkins, A. L., Connelly, P. W., Jones, P. J., & 
Vuksan, V. (2003). The Garden of Eden--plant based diets, the genetic drive to conserve 
cholesterol and its implications for heart disease in the 21st century. Comparative 
Biochemistry and Physiology. Part A, Molecular & Integrative Physiology., 136(1), 141-
151.  
Jones, P. J., & Varady, K. A. (2008). Are functional foods redefining nutritional requirements? 
Applied Physiology, Nutrition, and Metabolism, 33(1), 118-123.  
 23
Marlett, J. A. (1993). Dietary Fiber: A Candidate Nutrient?. Paper presented at the Nutritional 
Essentiality: A Changing Paradigm, Report of the Twelfth Ross Conference on Medical 
Research. 
Olson, J. A. (1996). Benefits and liabilities of vitamin A and carotenoids. Journal of Nutrition, 
126(4 Suppl), 1208S-1212S.  
Shils, M. E., Olson, J. A., Shike, M., & Ross, A. C. Modern Nutrition in Health and Disease. 
(1999).  (9th ed.): Lippincott Williams & Wilkins. 
Steele, R. D. (1993). Concluding Remarks. Paper presented at the Nutritional Essentiality: A 
Changing Paradigm, Report of the Twelfth Ross Conference on Medical Research. 
Tomás-Barberán, F.A., Andrés-Lacueva, C. (2012). Polyphenols and health: current state and 
progress Journal of Agricultural and Food Chemistry. 60(36), 8773-8775. 
Whitney., E. N., & Rolfes., S. R. Understanding Nutrition. (2002).  (9th ed.): Wadsworth Group. 
Williamson, G., & Holst, B. (2008). Dietary reference intake (DRI) value for dietary 
polyphenols: are we heading in the right direction? British Journal of Nutrition, 99 Suppl 
3, S55-58.  
U.S. Food and Drug Administration. (2009). Guidance for Industry: Evidence-based review 
system for the scientific evaluation of health claims. 
 
 
